See if you are eligible:

CLICK HERE

---

Study Information

Study Status

Recruiting

Cancer Type

Prostate Cancer​

Protocol Title

eHealth and information use by Australian men with prostate cancer.

Purpose of the Study

Prostate cancer is the most diagnosed cancer in Australia, with an estimated 18,110 new cases diagnosed in 2021. One in 6 Australian men will be diagnosed with prostate cancer by the age of 85. While most Australians use the internet in their day to day lives, little is known about information and technology use by men with prostate cancer. 

The PrE-Health study aims to understand the the impact of information resources and technology use on Australian men with prostate cancer. The study will assess how information resources and technology influence prostate cancer clinical and survivorship outcomes such as: disease progression rates, quality of life, psychology, and decision making.

Vertical Divider

Eligibility Criteria

Key inclusion criteria:
1. Australian adult male over the age of 18.
2. Biopsy confirmed diagnosis of prostate cancer. 
3. Has completed or is undergoing treatment for prostate cancer

• Including: surgery, radiotherapy, active surveillance, watchful waiting, focal therapy, androgen deprivation therapy, etc.

Key exclusion criteria:
1. Female, not Australian, or under the age of 18. 
2. No biopsy confirmed diagnosis of prostate cancer. 

Contact Email

info@prehealthstudy.org​

Detailed Information

Please see our Frequently Asked Questions.

​Funding

Westmead Clinical School, University of Sydney

​Principle Investigator

Professor Manish Patel

See if you are eligible for 'The PrE-Health Study' here​